Mineralys Therapeutics, Inc.

Filed a patent for "soluble pharmaceutical compositions comprising salts of disubstituted 1, 2, 4-triazine compound" on Fri, January 19, 2024

Filed a patent for "methods of treating hypertension with a combination of an aldosterone synthase inhibitor and a diuretic" on Tue, August 23, 2022

Filed a patent for "methods of treating hypertension in obese subjects" on Tue, August 23, 2022

Filed a patent for "methods of treating hypertension with a combination of an aldosterone synthase inhibitor and a diuretic" on Wed, November 16, 2022

Filed a patent for "cyp11b2 beta hydroxylase inhibitors for hypertension" on Thu, January 11, 2024